Evidence map›Paper›PMID 34419082›Full record

Trial reportJournal of the International Society of Sports Nutrition2021

Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists.

S C Broome, A J Braakhuis, C J Mitchell, T L Merry

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International Society of Sports Nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Coenzyme QNutrients · 2022
    Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Mitochondria Related Cell Death Modalities and Disease.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

S C BroomeDiscipline of Nutrition, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
A J BraakhuisDiscipline of Nutrition, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
C J MitchellSchool of Kinesiology, University of British Columbia, Vancouver, Canada.
T L MerryDiscipline of Nutrition, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand. t.merry@auckland.ac.nz.ORCID http://orcid.org/0000-0001-8699-500X
University of Auckland · NZUniversity of British Columbia · CA

Funding

Callaghan Innovation APOD1701
6 · The paper itself

Abstract

backgroundExercise increases skeletal muscle reactive oxygen species (ROS) production, which may contribute to the onset of muscular fatigue and impair athletic performance. Mitochondria-targeted antioxidants such as MitoQ, which contains a ubiquinone moiety and is targeted to mitochondria through the addition of a lipophilic triphenylphosphonium cation, are becoming popular amongst active individuals as they are designed to accumulate within mitochondria and may provide targeted protection against exercise-induced oxidative stress. However, the effect of MitoQ supplementation on cycling performance is currently unknown. Here, we investigate whether MitoQ supplementation can improve cycling performance measured as time to complete an 8 km time trial.

methodIn a randomized, double-blind, placebo-controlled crossover study, 19 middle-aged (age: 44 ± 4 years) recreationally trained (VO

resultsMean completion time for the time trial was 1.3% faster with MitoQ (12.91 ± 0.94 min) compared to placebo (13.09 ± 0.95 min, p = 0.04, 95% CI [0.05, 2.64], d = 0.2). There was no difference in RPE during the time trial between conditions (p = 0.82) despite there being a 4.4% increase in average power output during the time trial following MitoQ supplementation compared to placebo (placebo; 270 ± 51 W, MitoQ; 280 ± 53 W, p = 0.04, 95% CI [0.49, 8.22], d = 0.2). Plasma F

conclusionThese data suggest that MitoQ supplementation may be an effective nutritional strategy to attenuate exercise-induced increases in oxidative damage to lipids and improve cycling performance.

Indexed as

AdultAntioxidantsAthletic PerformanceBicyclingCross-Over StudiesDouble-Blind MethodF2-IsoprostanesHumansLipid PeroxidationMaleMiddle AgedMitochondria, MuscleMuscle, SkeletalOrganophosphorus CompoundsOxidative StressOxygen ConsumptionAntioxidantsF2-IsoprostanesmitoquinoneOrganophosphorus CompoundsPerformance-Enhancing SubstancesPlacebosReactive Oxygen SpeciesUbiquinoneAntioxidantMitochondriaOxidative stressPerformanceROS

Identifiers

PMID34419082
PMCPMC8379793
OpenAlexW3119338728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.